Telix Pharmaceuticals Limited (ASX:TLX)
Australia · Delayed Price · Currency is AUD 16.19
+1.15 (7.65%)
Aug 7, 2026, 4:10 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.5 billion as of August 7, 2026. Its market cap has decreased by -12.51% in one year.
Market Cap
5.50B
Enterprise Value
5.99B
Revenue
1.21B
Ranking
n/a
PE Ratio
n/a
Stock Price
16.19
ChartMarket Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.50B, an increase of 3,518.51%. That is a compound annual growth rate of 50.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 5.50B | 45.01% |
| Dec 31, 2025 | 3.79B | -53.95% |
| Dec 31, 2024 | 8.24B | 152.44% |
| Dec 29, 2023 | 3.26B | 41.89% |
| Dec 30, 2022 | 2.30B | 4.10% |
| Dec 31, 2021 | 2.21B | 108.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 63.39B |
| Mesoblast | 2.90B |
| Neuren Pharmaceuticals | 2.73B |
| PYC Therapeutics | 2.09B |
| Clarity Pharmaceuticals | 999.86M |
| Clinuvel Pharmaceuticals | 472.51M |
| Tetratherix | 400.04M |
| Racura Oncology | 396.99M |